These evidence altogether confirmed that as hs-CRP and AIP levels increased, the disease severity of PCAD patients aggravated, and both of them had predictive value for CAD occurrence in PCAD patients, with their combination exhibiting more prolonged efficiency. This evidence concerns the gene CRP and autoimmune pancreatitis.